Outcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning From the Past to Move Forward

Outcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning From the Past to Move Forward

The use of radiographic response as the primary end point in phase II osteosarcoma trials may limit optimal detection of treatment response because of the calcified tumor matrix. We performed this study to determine if time to progression could be used as an end point for subsequent studies.We perfo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Joanne P. Lagmay, Mark Krailo, Ha Dang, AeRang Kim, Douglas S. Hawkins, Orren Beaty, Brigitte C. Widemann, Theodore Zwerdling, Lisa Bomgaars, Anne‐Marie Langevin, Holcombe E. Grier, Brenda J. Weigel, Susan M. Blaney, Richard Görlick, Katherine A. Janeway
Format: Artigo
Sprache:Englisch
Veröffentlicht: 2016
Online-Zugang:https://doi.org/10.1200/jco.2015.65.5381
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Online

https://doi.org/10.1200/jco.2015.65.5381

Ähnliche Einträge